Yee et al., 1994 - Google Patents
Novel drug delivery systems.Yee et al., 1994
- Document ID
- 9716435431415198736
- Author
- Yee J
- Ashburn M
- Stanley T
- Publication year
- Publication venue
- Headache Quarterly
External Links
Snippet
New drug delivery systems provide unique improvements over traditional techniques of drug administration. Enhancement in a given drug's therapeutic ratio will mean less agent is required for a given effect. For example, transdermal or transmucosal delivery of a drug will …
- 239000003814 drug 0 title abstract description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying, e.g. spreading, media, e.g. remedies, on the human body ; Introducing media, e.g. remedies, into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9709162A (en) | Skin permeation enhancer compositions using acyl lactylates. | |
| Yee et al. | Novel drug delivery systems. | |
| GR3026364T3 (en) | Pharmaceutical composition for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics | |
| ATE89755T1 (en) | DEVICE FOR TRANSDERMAL APPLICATION OF MEDICATIONS. | |
| ZA933349B (en) | Transdermal administration of oxybutynin | |
| KR100321467B1 (en) | ||
| GB2316004A (en) | Novel formulations for transdermal delivery of pergolide | |
| TR200001891T2 (en) | ASPB28- Human insulin and its use. | |
| DK0630230T3 (en) | Pharmaceutical inhalation preparations | |
| JPS62500789A (en) | Nasal composition containing vitamin B↓1↓2 | |
| HK1063148A1 (en) | Novel formulations for the transdermal administration of fluoxetine | |
| EP0214254A1 (en) | Melatonin compositions and uses thereof. | |
| CS9001136A2 (en) | Method of transdermal therapeutical system's production with active substance's graded liberation and application for active substances' local or systemic administration | |
| KR910005858A (en) | Fatty acid therapy | |
| EP0290262A3 (en) | Improved nitrate therapy for angina pectoris | |
| Besana | Comparison of niaprazine and placebo in pediatric behaviour and sleep disorders: Double-blind clinical trial. | |
| EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
| Rana et al. | Local anaesthesia: Buffered or non-buffered? A comparative study | |
| 黄圣源 et al. | CLINICAL OBSERVATION ON TREATMENT OF DISORDERS OF THE OPTIC NERVE BY ACUPUNCTURE | |
| RU94025799A (en) | Method of treatment of idiopathic dermatomyositis | |
| 袁硕 et al. | 110 CASES OF MASTOSIS TREATED BY ACUPUNCTURE | |
| 王永祥 et al. | EFFICACY OF DIETHYLCARBAMAZINE CREAM ON LYMPHATIC FILARIASIS BY TRANSEPIDERMAL APPLICATION | |
| Tsaritsinsky | Treatment of paranoid schizophrenics with regard to the circadian biological rhythms. | |
| Kelimbetov et al. | Lincomycin concentration in the blood and tissues when administered by electrophoresis in children with acute and chronic hematogenic osteomyelitis | |
| 杨荫昌 et al. | POINT INJECTION COMBINED WITH ELECTRO-ACUPUNCTURE IN TREATMENT OF 300 CASES OF FACIAL PARALYSIS PERIPHERICA |